I have heard that there is now data that, for metabolic reasons that
are not very clear, post mortem blood levels of some psychotropic meds
rise exponentially, and are not an accurate assessment of the blood
level prior to death. Studies by Lilly Pharmaceuticals and the Los
Angeles Poison Control Center were referenced, but not cited.
Apparently one study involved Zyprexa, and another cited a wider range
of psychotropic meds. I would be interested in (1) finding any
original research and (2) a lay-person explanation of same. My
particular interest would be in paroxetine, if possible, but any of
the above studies would be helpful. |
Clarification of Question by
agp1071-ga
on
07 Feb 2005 21:31 PST
Thanks for your comment, pinkfreud. I should probably clarify that I
am looking for information to present to a Medical Examiner who has
listed a cause of death as paroxetine intoxication, when there was
absolutely zero possibility of this (I am positive -- not just
hopeful.) The post-mortem paroxetine level was off the charts, so
that's how the ME ruled. I want to be able to present evidence of the
research I referred to in my question which shows recent findings that
the pre and postmortem levels can be distinctly different, so we can
look at finding the real cause of death. The anniversary of death is
just a little over a month away, so I am under the gun in trying to
get this info as there is very possibly a wrongful death here.
Thanks.
|
Request for Question Clarification by
pinkfreud-ga
on
07 Feb 2005 21:44 PST
Several hours of searching has not turned up anything specific to
paroxetine. I hope another Researcher will be able to help you. It's
an interesting subject, so my time was well spent even if I don't
qualify for the "prize."
Have you considered hiring an expert to testify? Has the evidence been re-tested?
|
Request for Question Clarification by
pinkfreud-ga
on
07 Feb 2005 21:56 PST
One thing that is worth mentioning is that death from a paroxetine
overdose is extremely rare.
"Paxil was approved by the FDA in 1993 to treat depression,
generalized anxiety disorder, social anxiety disorder, panic disorder,
obsessive compulsive disorder, and post traumatic stress syndrome.
GlaxoSmithKline is the pharmaceutical giant responsible for Paxil
production.
Since the approval of this drug, more than 350 cases of accidental or
deliberate Paxil overdose have been reported worldwide. Of these
reported Paxil overdose cases, about fifty patients died as a result.
In seventeen cases the patient died from a Paxil overdose that
involved only the use of Paxil and eight deaths were caused by Paxil
overdose and the ingestion of other drugs or alcohol or in the
presence of compounding comorbid disorders."
http://www.onlinelawyersource.com/paxil/overdose.html
|
Request for Question Clarification by
pinkfreud-ga
on
07 Feb 2005 22:01 PST
One more thing: it might be useful to Researchers to know whether the
drug in question was paroxetine hydrochloride or paroxetine mesylate.
|
Clarification of Question by
agp1071-ga
on
08 Feb 2005 19:22 PST
pinkster, many thanks again for your time. You are one relentless
researcher, and I appreciate your energy and perspective. I think I
have pretty much decided not to sue, so an expert is not necessarily
what I need (despite my reference to time limit and wrongful death) I
only want the death investigated, and want to give some rationale for
that -- not sure exactly if there is a time-limit on getting that to
happen, but don't want to take any chances. Finding the research I've
heard about (from an acquaintance who is on a psychopharmacology
bulletin board with other docs) is the best way I know to help educate
those who should already know this, but don't yet, because the
information is so brand new (just came across the bulletin board a
month or so ago). BTW, I have no way to follow that thread -- only to
go after the sources they cited (i.e., Lilly and LA Poison Control).
Thanks again for trying :)
|
Request for Question Clarification by
pinkfreud-ga
on
08 Feb 2005 23:06 PST
I'm still taking periodic stabs at this, but I'm not catching
anything. Are you quite certain that the drug studies you're seeking
show some kind of recently noted phenomenon that is unique to
psychotropic drugs, and not post-mortem redistribution, as mentioned
in the link I posted below? It just seems odd to me that a new
discovery such as this would be so difficult to find on the Web. I
would expect there to be numerous write-ups of it. You might want to
query your friend who is on the psychopharmacology forum in more
depth. If the studies were demonstrating post-mortem redistribution,
finding them probably wouldn't be all that useful, since post-mortem
redistribution should be something with which the M.E. is quite
familiar.
|
Clarification of Question by
agp1071-ga
on
09 Feb 2005 18:14 PST
re: pinkfreud's Feb 8th comments/request for clarification: Thanks
again, pinkfreud. My certainty regarding the recency and specificity
of the elusive research rests only with my assessment of the integrity
of my source, a psychiatrist acquaintance who sent me the exact text
of the psychopharmacology board posts. It did seem to suggest very
new findings, which I don't even know had been made public yet. I'm
hard-pressed to know where to start finding that (I have asked the
acquaintance if he is able to query the board for specifics, but so
far he hasn't. He has several practices in different parts of the
state and is stretched beyond belief.) At any rate, if this research
is not yet ready for prime-time, I don't know how to get to it. But,
again, thanks for your thoughts and your time. It is baffling. What
I haven't done is called LA Poison Control or Eli Lilly, maybe that's
the next step?
|
Re: spookysr's comment: Thanks for the time you took to give your
perspective. It all made sense to me. Here's some clarification to
illustrate what didn't fit: First, I already have the ME's report.
Second, decedent was only on Paroxetine (my reference to Zyprexa was
specific to the research I have heard about -- never to the decedent
-- I haven't heard of anything specific to Paroxetine, but I am
interested in securing the research on Zyprexa and psychotropic meds
as a general category, which are the two research reports I *have*
heard about, because they show a general tendency for psychotropic
drugs to act differently postmortem. Third, there was no possibility
of an accidental or intentional overdose of paroxetine. I mentioned
this in my original post -- that I am positive of this, not just
hopeful or in denial. I could cite many reasons for my certainty (no
access, pills have been counted, no access, gentleman was never out of
eyesight, no access, nobody else had access, etc.) but it's not worth
the time -- it is just a fact, and it is the reason I am in search of
evidence to support the off-the-chart levels of other psychotropic
meds. Fourth, I am not interested in suing the drug companies.
Fifth, I am not intersted in suing anybody, so I wouldn't be getting
in my lawyer's way. Sixth, I know that others (whom I have no way of
reaching) have cited such evidence to THEIR medical examiners, who
have subsequently changed cause of death in light of new information.
If this is what fits here, I want that to happen. And I want the
death investigated to learn what really went on (my theory is heart
attack, at a facility that should have had a defib but didn't -- yet
is probably getting off the hook due to the ME's misguided cause of
death.) |